2010

August 9th, 2010
,
U.S. DOE's Energy Empowers: In northeastern Oregon, ZeaChem, a Colorado-based biofuel company, recently broke ground on a 250,000 gallon integrated cellulosic biorefinery.
August 9th, 2010
,
NetBanker: I've been looking forward to the day when financial companies would begin to leverage mobile phone location to fight payments fraud.
August 4th, 2010
Northwest Innovation: Seattle-based doxo.com, the paperless billing startup headed by Steve Shivers and backed by Mohr Davidow Ventures and Bezos Expeditions, is hailing its naming to a study of insurance technology companies by analyst firm Forrester.
August 3rd, 2010
Net Imperative: Audience targeting is now the cornerstone of most online ad campaigns, helping to boost revenue for both branding and direct response, according to a new survey.
August 3rd, 2010
PV-Tech.org: Before Solyndra's trials, tribulations, and triumphs put that company in the media and industry crosshairs in recent months, the company that received the lion's share of bete noire/tech-innovator darling attention among the emergent thin-film PV crowd was Nanosolar.
August 1st, 2010
,
Ethanol Producer Magazine: The commitment to cellulosic ethanol continues to gain ground in different ways.
July 30th, 2010
,
Fast Company: The Salton Sea is one of California's most intriguing attractions. It's one of the planet's largest inland seas, the home of over 400 species of birds, the product of an irrigation project overflow, one of the planet's lowest points and, perhaps most creepily, surrounding by a number of ghost towns.
July 29th, 2010
Forrester Research: Effective vertical strategies are becoming more critical for tech vendors as they try to address the core business problems - not just the pure technical problems - of their customers.
July 21st, 2010
San Francisco Business Times: Tethys Bioscience Inc. raised $23 million in venture financing and closed a $10 million loan to help it grow its sales force and expand the market for its predictive diabetes test.
July 14th, 2010
Technology Review: As a genre, personalized medicine has yet to deliver many individualized treatments. But progress has been more tangible on the diagnostics side.